Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2004 3
2005 8
2006 4
2007 3
2008 4
2009 12
2010 20
2011 19
2012 17
2013 9
2014 8
2015 10
2016 8
2017 7
2018 10
2019 9
2020 9
2021 15
2022 16
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

169 results

Results by year

Filters applied: . Clear all
Page 1
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
Pedrazzi JFC, Ferreira FR, Silva-Amaral D, Lima DA, Hallak JEC, Zuardi AW, Del-Bel EA, Guimarães FS, Costa KCM, Campos AC, Crippa ACS, Crippa JAS. Pedrazzi JFC, et al. Among authors: zuardi aw. Psychopharmacology (Berl). 2022 Sep;239(9):2713-2734. doi: 10.1007/s00213-022-06196-4. Epub 2022 Jul 29. Psychopharmacology (Berl). 2022. PMID: 35904579 Review.
Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder.
de Almeida CMO, Brito MMC, Bosaipo NB, Pimentel AV, Tumas V, Zuardi AW, Crippa JAS, Hallak JEC, Eckeli AL. de Almeida CMO, et al. Among authors: zuardi aw. Mov Disord. 2021 Jul;36(7):1711-1715. doi: 10.1002/mds.28577. Epub 2021 Mar 22. Mov Disord. 2021. PMID: 33754375 Clinical Trial.
Cannabis and anxiety: a critical review of the evidence.
Crippa JA, Zuardi AW, Martín-Santos R, Bhattacharyya S, Atakan Z, McGuire P, Fusar-Poli P. Crippa JA, et al. Hum Psychopharmacol. 2009 Oct;24(7):515-23. doi: 10.1002/hup.1048. Hum Psychopharmacol. 2009. PMID: 19693792 Review.
History of cannabis as a medicine: a review.
Zuardi AW. Zuardi AW. Braz J Psychiatry. 2006 Jun;28(2):153-7. doi: 10.1590/s1516-44462006000200015. Epub 2006 Jun 26. Braz J Psychiatry. 2006. PMID: 16810401 Review.
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.
Crippa JA, Derenusson GN, Ferrari TB, Wichert-Ana L, Duran FL, Martin-Santos R, Simões MV, Bhattacharyya S, Fusar-Poli P, Atakan Z, Santos Filho A, Freitas-Ferrari MC, McGuire PK, Zuardi AW, Busatto GF, Hallak JE. Crippa JA, et al. J Psychopharmacol. 2011 Jan;25(1):121-30. doi: 10.1177/0269881110379283. Epub 2010 Sep 9. J Psychopharmacol. 2011. PMID: 20829306 Clinical Trial.
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.
Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi AE, Martín-Santos R, Hallak JE, Zuardi AW, Crippa JA. Bergamaschi MM, et al. Neuropsychopharmacology. 2011 May;36(6):1219-26. doi: 10.1038/npp.2011.6. Epub 2011 Feb 9. Neuropsychopharmacology. 2011. PMID: 21307846 Free PMC article. Clinical Trial.
169 results